Does PMI cover PSA testing?

Not routinely for asymptomatic screening — this is considered preventative. Once symptoms or elevated PSA emerge and a GP refers, all diagnostic work (further PSA, mpMRI, biopsy) is fully covered on comprehensive policies.

Is robotic (da Vinci) prostatectomy covered?

Yes on almost all UK PMI policies with cancer cover — Bupa, AXA, Aviva, Vitality, Freedom and The Exeter all fund robotic surgery at HCA, Cleveland Clinic London, Nuffield and Spire.

Does PMI cover PSMA-PET scans?

Increasingly yes on full-cover policies — Bupa, AXA and Aviva fund PSMA-PET where clinically recommended for staging or biochemical recurrence. Always pre-authorise.

Are next-generation drugs like abiraterone and enzalutamide covered?

Yes on full-cover policies. Core policies may cap. Always check the drug list in the policy schedule.

How fast can I see a private urologist?

Typically 3–7 working days. mpMRI within 10 days. Targeted biopsy within 2–3 weeks. Compared to 6–8 weeks on the NHS.

Can I have active surveillance on PMI?

Yes — PMI continues to fund regular monitoring (PSA, mpMRI, biopsies) for men on active surveillance for low-risk prostate cancer.

Is brachytherapy covered?

Yes on comprehensive policies — brachytherapy is a NICE-approved option and fully funded where clinically appropriate.

What if I have a strong family history?

Family history alone is not a pre-existing condition and does not affect underwriting terms on moratorium. Buy cover before any PSA elevation.

How UK PMI funds private prostate cancer diagnosis (mpMRI, PSMA-PET), robotic prostatectomy, radiotherapy, brachytherapy and hormone therapy. From £68.42/mo.

Private Prostate Cancer Cover UK

Prostate cancer is the most common cancer in UK men (~55,100/year). Full-cover PMI funds mpMRI, targeted biopsy, PSMA-PET staging, robotic prostatectomy, external beam radiotherapy, brachytherapy, hormone therapy and next-generation drugs (abiraterone, enzalutamide). Premiums for a 55-year-old man on comprehensive + full cancer cover start from £128/month.

Around 55,100 UK men are diagnosed with prostate cancer each year (Cancer Research UK). Screening is not routine — most diagnoses follow PSA testing after symptoms or family history. Private pathways collapse the diagnostic timeline from 6–8 weeks (NHS) to 10–14 days.
A full-cover PMI policy funds: same-week urology consultation, PSA and multi-parametric MRI (mpMRI) within 10 days, MRI-guided targeted biopsy, PSMA-PET staging where clinically indicated, radical prostatectomy (increasingly robotic — da Vinci system), external beam radiotherapy (IMRT), brachytherapy, high-intensity focused ultrasound (HIFU) where appropriate, and androgen deprivation therapy (LHRH agonists, anti-androgens).
For advanced disease, full-cover policies fund next-generation hormonal therapies (abiraterone, enzalutamide, apalutamide) and chemotherapy (docetaxel, cabazitaxel). Coverage of Lu-177 PSMA radioligand therapy (a newer treatment) is emerging — always confirm before diagnosis.

PremierPMI is a UK private medical insurance broker specialising in whole-of-market placement across 10+ leading UK health insurers including Bupa, AXA Health, Aviva, Vitality, WPA, Freedom Health, The Exeter, General & Medical and National Friendly. FCA regulated (Tesha Family Ltd, FRN 1029667). Speak to a broker on 020 4525 0884, WhatsApp 07515 703307, or email contact@premierpmi.co.uk.

Speak to a UK PMI broker

PremierPMI's brokers are available Monday to Friday 9am to 5:30pm. Call 020 4525 0884, message us on WhatsApp 07515 703307, or email contact@premierpmi.co.uk. You can also request a callback or meet our team.